非转移性肾细胞癌伴下腔静脉瘤栓的手术治疗:系统评价与网状Meta分析
结果显示微创手术(MIS)估计出血量、总体并发症率及住院时间更优,机器人手术手术时间更短,但证据受回顾性设计与选择偏倚限制。
要点
- MIS组估计出血量显著低于开放手术(机器人918.2ml、腹腔镜253.7ml vs 开放1488.4ml,p<0.001)。
- 总体并发症率机器人28.5%、腹腔镜12.6%、开放28.9%(p=0.05),主要并发症率分别为5.1%、2.8%、12.9%(p=0.02)。
- 网状Meta分析示MIS总体并发症OR更低(机器人0.37,p=0.01;腹腔镜0.24,p<0.001),住院时间更短。
核心结论
- MIS在经选择的患者中围手术期结局更优,但受选择偏倚影响,无法对MIS与开放手术的比较效果得出确定性结论。
研究设计与样本
- 系统检索PubMed、Embase、Scopus和Web of Science自建库至2025年1月10日,遵循PRISMA指南,PROSPERO注册号CRD42022330114。
- 采用随机效应模型进行比例Meta分析和比较研究的网状Meta分析。
主要发现
- 常规Meta分析示各术式平均手术时间相似(p=0.07),MIS平均估计出血量显著低于开放手术(p<0.001)。
- 总体并发症率机器人28.5%、腹腔镜12.6%、开放28.9%(p=0.05),主要并发症率分别为5.1%、2.8%、12.9%(p=0.02)。
- 网状Meta分析示机器人手术时间较开放缩短58.7分钟(p<0.001),腹腔镜缩短43.3分钟(p=0.01)。
- 总体并发症OR机器人0.37(p=0.01)、腹腔镜0.24(p<0.001);住院时间机器人缩短3.8天、腹腔镜缩短4.8天(p<0.05)。
- 网状Meta分析中主要并发症率差异无统计学意义。
关键数值与推荐
- MIS平均估计出血量:机器人918.2ml,腹腔镜253.7ml;开放手术1488.4ml(p<0.001)。
- 总体并发症率:机器人28.5%,腹腔镜12.6%,开放28.9%(p=0.05)。
- 主要并发症率:机器人5.1%,腹腔镜2.8%,开放12.9%(p=0.02)。
- 网状Meta分析手术时间差:机器人-58.7分钟(p<0.001),腹腔镜-43.3分钟(p=0.01)。
- 网状Meta分析总体并发症OR:机器人0.37(p=0.01),腹腔镜0.24(p<0.001);住院时间差:机器人-3.8天,腹腔镜-4.8天(p<0.05)。
临床怎么用
- 在经验丰富的中心,对经仔细选择的Mayo I-II级瘤栓患者,MIS可能与更优的围手术期结局相关。
- 复杂瘤栓仍以开放手术为标准,选择MIS需充分评估瘤栓级别与中心经验。
局限性
- 纳入研究多为回顾性设计。
- 存在有利于开放手术治疗晚期瘤栓的选择偏倚。
- 肿瘤学结局报告不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Inferior vena cava (IVC) tumor thrombus can impact the surgical management of locally advanced renal cell carcinoma (RCC). While open surgery remains the standard for complex thrombi, minimally invasive surgery (MIS) is increasingly adopted. The aim of this review was to compare perioperative outcomes across the different surgical approaches for IVC thrombectomy in nonmetastatic RCC. METHODS: We systematically searched the PubMed, Embase, Scopus, and Web of Science databases from inception to January 10, 2025 according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The review protocol was registered on PROSPERO (CRD42022330114). Retrospective and prospective studies reporting operative time (OT), estimated blood loss (EBL), complication rates, or length of stay (LOS) after IVC thrombectomy were included. A meta-analysis of proportions and a network meta-analysis (NMA) of comparative studies were performed using random-effects models. KEY FINDINGS AND LIMITATIONS: Sixty-six studies (3241 patients) were included. Conventional meta-analysis revealed that mean OT was similar across approaches (p = 0.07), while mean EBL was significantly lower with MIS (robotic: 918.2 ml; laparoscopic: 253.7 ml) than with open surgery (1488.4 ml; p < 0.001). Overall complication rates were 28.5% with robotic, 12.6% with laparoscopic, and 28.9% with open surgery (p = 0.05), with corresponding major complication rates of 5.1%, 2.8%, and 12.9% (p = 0.02). NMA revealed shorter mean OT for robotic (-58.7 min; p < 0.001) and laparoscopic (-43.3 min; p = 0.01) approaches versus open surgery, and lower odds ratios for overall complications (robotic 0.37, p = 0.01; laparoscopic 0.24, p < 0.001) with MIS. Mean LOS was also shorter with MIS (robotic: -3.8 d; laparoscopic: -4.8 d; p < 0.05). Differences in major complication rates were not significant on NMA. Limitations include the retrospective design of the studies included, selection bias favoring open surgery for advanced thrombi, and under-reporting of oncological outcomes. CONCLUSIONS AND CLINICAL IMPLICATIONS: High-quality comparative evidence on MIS for IVC thrombectomy is limited and affected by substantial selection bias, which restricts robust comparisons to open surgery. Our findings suggest that MIS is associated with favorable perioperative outcomes in carefully selected patients, mainly with Mayo I-II thrombi in experienced centers, but no definitive conclusions on their comparative effectiveness versus open surgery can be drawn.
引用
- Amparore D, Pandolfo SD, Bertolo R, et al. Surgical Management of Nonmetastatic Renal Cell Carcinoma with Inferior Vena Cava Thrombus: A Systematic Review and Network Meta-analysis. Eur Urol Oncol. 2026. PMID: 41644363. doi:10.1016/j.euo.2026.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。